John E. Kao - 25 Mar 2024 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ALHC
Reported as of: 25 Mar 2024
Net transaction value: -$2,568,067
SEC form: 4
Accepted by SEC: 11 Jul 2025, 17:14:37 UTC
Prior SEC filing: 18 Mar 2024
Next SEC filing: 18 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao

Key filing fact

John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 11 Jul 2025.

Key facts

This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 Jul 2025, 17:14.

Change

Previous filing in this sequence was filed on 18 Mar 2024.
Current net transaction value: -$2,568,067.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001222028 Primary reporting owner

KAO JOHN E

Relationship: Chief Executive Officer, Director
Address: 1100 W. TOWN & COUNTRY RD., SUITE 1600, ORANGE
Signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Signature date: 11 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALHC transaction

Common Stock

Tax liability

Transaction value: $154,267
Shares: -33,319
Change %: -0.68%
Price: $4.63
Shares after: 4,888,586
Date: 25 Mar 2024
Ownership: Direct
Footnotes: F1, F2

ALHC transaction

Common Stock

Sale

Transaction value: $2,413,800
Shares: -180,000
Change %: -10%
Price: $13.41
Shares after: 1,553,100
Date: 10 Jul 2025
Ownership: See Footnote
Footnotes: F3, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Represents the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based restricted stock units ("RSUs"). The withholding of these shares occurred automatically upon the vesting of the RSUs, and as such, no investment decision was made by the Reporting Person in connection with this transaction. Vesting occurred on 3/25/2024 and the transaction is being reported late due to an inadvertent administrative oversight.

Footnote F2

Reflects the number of shares beneficially owned as of the date of this Form 4. The number of shares beneficially owned immediately following the reported transaction was 2,710,653.

Footnote F3

Date of Rule 10b5-1 plan adoption: 03/12/2025

Footnote F4

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.28 to $13.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Footnote F5

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.